Multiple Myeloma ICD-10-CM Codes
Delve into the 2023 ICD codes for Multiple Myeloma. Understand the codes, billability, and clinical relevance for this type of blood cancer.
What ICD Codes Are Used for Multiple Myeloma?
When addressing Multiple Myeloma, it's essential to be familiar with the specific Multiple Myeloma ICD codes for accurate clinical documentation and billing. Multiple Myeloma is a type of blood cancer that originates in the plasma cells in the bone marrow. Here are some commonly used ICD codes related to this condition:
- C90.00 - Multiple myeloma not having achieved remission: This code is used for cases diagnosed with multiple myeloma where the disease has not yet reached a state of remission.
Using the right codes ensures that patients receive the appropriate care and that healthcare providers are reimbursed accurately.
Which Multiple Myeloma ICD Codes Are Billable?
The ICD code mentioned for Multiple Myeloma, C90.00, is billable as it represents a specific medical condition that requires intervention. Proper documentation is crucial to ensure accurate billing and prevent potential discrepancies.
Clinical Information
Multiple Myeloma has specific clinical characteristics:
- It's a cancer of plasma cells, a white blood cell type responsible for producing antibodies.
- Symptoms include bone pain, fatigue, frequent infections, and kidney problems.
- Diagnosis often involves blood tests, bone marrow biopsy, and imaging studies.
- Treatment options include chemotherapy, targeted therapy, stem cell transplant, and radiation therapy.
- Early detection and treatment can improve outcomes and quality of life.
Synonyms Include:
- Plasma Cell Myeloma
- Kahler's Disease
- Myelomatosis
- Plasma Cell Dyscrasia
- Bone Marrow Cancer
Commonly asked questions
The exact cause of multiple myeloma is unknown. However, specific genetic mutations and environmental factors may increase the risk of developing this cancer.
Multiple myeloma is diagnosed through blood tests, urine tests, imaging studies, and a bone marrow biopsy to examine the plasma cells.
While multiple myeloma is often treatable, it's considered incurable. However, treatments can help manage symptoms, reduce complications, and improve the quality of life.